The B2B Podcast Index
Vertical SaaS with Fexingo: Industry-Specific Software for Healthcare, Construction, Legal

How Vertical SaaS Is Digitizing the Hearing Aid Industry

Vertical SaaS with Fexingo: Industry-Specific Software for Healthcare, Construction, Legal · 2026-06-24 · 11 min

Substance score

33 / 100

Five dimensions, 20 points each

Insight Density9 / 20
Originality6 / 20
Guest Caliber2 / 20
Specificity & Evidence10 / 20
Conversational Craft6 / 20

What our scoring noted

Our reviewer’s read on each dimension, with quotes from the episode.

Insight Density

9 / 20

The episode contains a handful of genuinely useful operational details (admin time reduction, subscription pricing, clinic count, FDA classification strategy) but the overall framing recycles standard vertical SaaS talking points and never goes deeper than a surface primer. The manufacturing/3D-printing angle is the most novel segment.

The average independent clinic spends about 12 hours per week on administrative paperwork. Audibel's software cuts that to roughly two hours.
Audibel's platform is fda registered as a medical device data system, which means it can receive, transmit, and display data, but it doesn't control the device directly.

Originality

6 / 20

Almost every structural argument — depth over breadth, high LTV/low churn, moat from domain expertise, niche too small for horizontal players — is canonical vertical SaaS doctrine repeated verbatim. The FDA registration angle shows a flicker of nuanced thinking but is underdeveloped.

So it's a classic vertical SaaS play: high lifetime value, low churn, and a niche that's too small for the horizontal players to care about.
And that's why we keep covering vertical SaaS on this show. It's a business model that aligns perfectly with the needs of specialized industries.

Guest Caliber

2 / 20

There is no guest — this is a scripted co-host dialogue between two generalist commentators who are clearly outside observers of the audiology industry, evidenced by their personal anecdotes substituting for practitioner knowledge.

My grandmother got hearing aids five years ago and she had to go back to the clinic four times for adjustments.
I mean, my dad is 72 and still prints out his emails.

Specificity & Evidence

10 / 20

The episode names companies, quotes pricing ($300/month), market size ($12B by 2030), clinic count (12,000), and operational metrics (40% follow-up reduction, 24-hour turnaround), but sourcing is opaque throughout — 'Audibel found that' and 'clinics report' with no citations, and at least one named entity (Audibel as a pure SaaS startup) appears constructed rather than verified.

Around $300 per month per clinic, with a setup fee. They also take a small transaction fee on insurance claims processed through the platform.
Sonova acquired a software company called Audia in 2023, but that was more focused on hearing test equipment.

Conversational Craft

6 / 20

Luna's questions function as scripted prompts to advance a prepared narrative rather than genuine probing; she occasionally flags a tension ('pretty lean revenue model') but never follows through with real pressure, and no claim is meaningfully challenged or stress-tested.

That seems like a pretty lean revenue model for such a specialized product.
Can a SaaS platform really improve access in those markets? I mean, you still need a physical clinic and an audiologist.

Conversation analysis

Computed from the transcript - who did the talking, and the verbal tics along the way.

Filler words

so16like4right4actually3I mean2kind of2you know1

Episode notes

Lucas and Luna explore how vertical SaaS is transforming the hearing aid industry, a market serving 466 million people worldwide but still reliant on paper charts and manual fitting. They focus on a specific case: the company Audibel (not the hardware brand) that built a cloud-based platform for audiologists to manage patient intake, hearing tests, device tuning, and insurance claims. Lucas breaks down the economics: the average independent hearing clinic spends 12 hours per week on paperwork, and Audibel's software cuts that to 2 hours, increasing patient volume by 20 percent. Luna challenges whether elderly patients adopt the technology, and Lucas shares data showing 70 percent of patients over 65 use a smartphone for hearing aid adjustments. They touch on competition from big players like Sonova and Cochlear, and the episode closes with a question about whether vertical SaaS can democratize access in underserved markets. Tune in for a data-driven look at a niche industry going digital.

Full transcript

11 min

Transcribed and scored by The B2B Podcast Index.

Lucas: There are about 466 million people worldwide with disabling hearing loss, and the vast majority of them get their hearing aids from small independent clinics. Until very recently, those clinics ran on paper charts, fax machines, and a lot of manual guesswork. Luna: And you're about to tell me that a vertical SaaS company has changed all that. Lucas: Exactly. The company is called Audibel — not the hearing aid brand, but a software startup that built a cloud-based platform specifically for audiologists. It handles patient intake, hearing tests, device tuning, and insurance claims, all in one place. Luna: So they're not making hardware. They're the operating system for the hearing clinic. Lucas: That's the right way to think about it. And the numbers are pretty striking. The average independent clinic spends about 12 hours per week on administrative paperwork. Audibel's software cuts that to roughly two hours. That means more time with patients, and clinics report a 20 percent increase in patient volume after adoption. Luna: Twenty percent is huge for a small business. But I have to ask — hearing aid patients skew older. Are they actually adopting the technology? I mean, my dad is 72 and still prints out his emails. Lucas: That's the first question everyone asks. And the data is surprisingly positive. Audibel found that 70 percent of patients over 65 already use a smartphone for hearing aid adjustments. The software has a patient-facing app that lets them tweak volume and program settings. So the friction isn't on the patient side — it's on the clinic side. Luna: So the software solves the clinic's workflow problem, and the patient gets a better experience as a side effect. Lucas: Exactly. And that's where the vertical SaaS model shines. You're not trying to build a generic CRM and bolt on hearing-aid features. You build the whole stack around the specific workflow. The hearing test results flow directly into the fitting software. The fitting software talks to the insurance claim system. It's all integrated. Luna: Who are they competing with? I imagine the big hardware players like Sonova or Cochlear might have their own software. Lucas: They do. Sonova owns Phonak and has a clinic management platform called NOAH. But NOAH is more of a compatibility layer — it connects different devices, but it's not a full practice management system. Audibel competes more with legacy EHR vendors like Practice Fusion that have a hearing module, but those are clunky and not purpose-built. Luna: So Audibel's edge is depth over breadth. Lucas: Exactly. They know that an audiologist's day involves specific steps: initial consultation, hearing test, device selection, fitting, follow-up. Each step has its own data requirements and regulatory paperwork. A general EHR doesn't capture that nuance. Audibel's software is essentially a workflow engine for that exact sequence. Luna: What's the business model? Per clinic per month? Lucas: Yes, subscription-based. Around $300 per month per clinic, with a setup fee. They also take a small transaction fee on insurance claims processed through the platform. That aligns incentives — they only make more when the clinic processes more claims. Luna: Interesting. So they're essentially betting on the clinic's growth. Lucas: Right. And that model works because hearing aid adoption is growing. The global market is expected to reach $12 billion by 2030, driven by aging populations and increased awareness. But the real opportunity is in markets like India and Brazil, where hearing loss is prevalent but access to clinics is limited. Luna: Can a SaaS platform really improve access in those markets? I mean, you still need a physical clinic and an audiologist. Lucas: You do, but Audibel is working on a tele-audiology module that lets technicians in rural areas conduct basic tests and send the data to an audiologist in a city for diagnosis. That could dramatically extend the reach of a single specialist. Luna: Interesting. So the software becomes a force multiplier for the existing workforce. Lucas: Exactly. And that's the kind of scalability that makes vertical SaaS so powerful. You're not just digitizing a paper process — you're reimagining how the service can be delivered. Luna: I want to zoom in on the patient experience for a second. My grandmother got hearing aids five years ago and she had to go back to the clinic four times for adjustments. Does this software reduce that? Lucas: It does. The fitting software uses real-time feedback from the patient during the test to fine-tune the device. And after the fitting, the patient can use the app to make minor adjustments at home. Some clinics report a 40 percent reduction in follow-up visits. Luna: That's a game-changer for elderly patients who have trouble getting to appointments. Lucas: Absolutely. And it's good for the clinic too — fewer no-shows, more capacity for new patients. It's a win-win. Luna: Alright, let's talk about the competition again. You mentioned Sonova and Cochlear. Are any of them acquiring vertical SaaS startups to defend their turf? Lucas: There's been some M&A activity. Sonova acquired a software company called Audia in 2023, but that was more focused on hearing test equipment. Cochlear has its own patient management platform but it's tightly integrated with its implants. The independent software space is still fragmented, and Audibel is one of the few pure-play vertical SaaS companies in hearing. Luna: So there's room for consolidation or a bigger player to enter. Lucas: Definitely. But the barrier to entry is high because you need deep domain expertise. You can't just hire a few engineers and build a hearing aid platform. You need to understand audiology workflows, insurance coding, and device interoperability. That's a moat. Luna: Before we move on, I want to touch on something you said earlier about the subscription model and transaction fees. That seems like a pretty lean revenue model for such a specialized product. Lucas: It is, but the unit economics work. The customer acquisition cost is low because the market is small and concentrated — there are only about 12,000 independent hearing clinics in the US. Audibel's sales team can call them directly. Churn is low because once a clinic trains its staff on the platform, switching costs are high. Luna: So it's a classic vertical SaaS play: high lifetime value, low churn, and a niche that's too small for the horizontal players to care about. Lucas: Exactly. And that's why we keep covering vertical SaaS on this show. It's a business model that aligns perfectly with the needs of specialized industries. Luna: You know, it's funny. We talk about these niche industries and the software that transforms them, and I think a lot of our listeners are probably running or building something similar. That's actually why we keep these conversations going — because we genuinely believe this stuff matters. Lucas: We do. And we deliberately keep these episodes free of ads. No sponsors, no interruptions. Just the story. If you find value in that approach and want to support it, the simplest way is to buy me a coffee dot com slash fexingo. That's all lowercase: buy me a coffee dot com slash fexingo. It helps us keep the show independent and focused on the substance. Luna: Yeah, no pressure. We're just glad you're listening. Lucas: Alright, back to hearing aids. So we've talked about the software transforming clinics. But there's another angle: how vertical SaaS is changing the hearing aid manufacturing side. Luna: I didn't realize manufacturing was part of this story. Lucas: It is. Hearing aids are highly customized — they're molded to the patient's ear canal. Traditionally, that required a physical impression, which was sent to a lab, which took a week. Now, some companies are using 3D scanning and printing, and vertical SaaS platforms manage the entire workflow from scan to print. Luna: So the software coordinates the supply chain. Lucas: Exactly. One company, called Lantos Technologies, uses a 3D scanner that captures the ear canal shape in under a minute. The data goes to a cloud platform that designs the shell and sends it to a 3D printer. The turnaround time drops from a week to 24 hours. Luna: That's a huge improvement for patient satisfaction. Lucas: And for the clinic's cash flow. They can fit the patient in one visit instead of two. That's more revenue per appointment. Luna: So vertical SaaS is touching both the clinical and manufacturing sides of hearing aids. That's a pretty comprehensive transformation. Lucas: It is. And I think we'll see more of that integration. The clinic software will eventually talk directly to the manufacturing software, creating a seamless loop from diagnosis to delivery. Luna: What about the hearing aid itself? Are there any software-only hearing aids coming? Lucas: Interesting question. There are some startups working on software-defined hearing aids, where the signal processing is done by an app rather than the device hardware. But that's still early. The regulatory hurdles are significant. Luna: Right, because hearing aids are medical devices. Lucas: Exactly. The FDA classifies them as Class II devices, so any software that affects the device's function needs clearance. That raises the bar for startups. Luna: But it also creates a moat for companies that have already cleared that hurdle. Lucas: Exactly. Audibel's platform is fda registered as a medical device data system, which means it can receive, transmit, and display data, but it doesn't control the device directly. That's a smart regulatory strategy. Luna: So they stay on the right side of the line while still adding value. Lucas: Bingo. And that's the kind of nuanced thinking that makes vertical SaaS companies so interesting. They understand the regulatory landscape of their industry and build accordingly. Luna: Alright, I think we've covered a lot of ground. Any final thoughts on where this is headed? Lucas: I think the next frontier is ai assisted diagnostics. Imagine a platform that analyzes a patient's hearing test results and recommends a specific device and tuning settings. That would reduce the skill barrier for audiologists and potentially allow more clinics to open in underserved areas. Luna: So vertical SaaS could actually democratize access to hearing care. Lucas: That's the hope. And it's a good note to end on. Thanks for listening.

All Vertical SaaS with Fexingo: Industry-Specific Software for Healthcare, Construction, Legal episodes →